No photo of Deborah Toppmeyer

View Scopus Profile

Deborah Toppmeyer

  • 3215 Citations
  • 22 h-Index
1992 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Deborah Toppmeyer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
9-aminocamptothecin Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

  • 3215 Citations
  • 22 h-Index
  • 48 Article
  • 8 Review article
  • 1 Editorial
  • 1 Letter

5-Year Results of a Prospective Phase 2 Trial Evaluating 3-Week Hypofractionated Whole Breast Radiation Therapy Inclusive of a Sequential Boost

Gupta, A., Khan, A. J., Yegya-Raman, N., Sayan, M., Ahlawat, S., Ohri, N., Goyal, S., Moore, D. F., Eladoumikdachi, F., Toppmeyer, D. & Haffty, B. G., Oct 1 2019, In : International Journal of Radiation Oncology Biology Physics. 105, 2, p. 267-274 8 p.

Research output: Contribution to journal › Article

acceleration (physics)
breast
radiation therapy
Breast
Radiotherapy

Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients

Sayan, M., Abou Yehia, Z., Gupta, A., Toppmeyer, D., Ohri, N. & Haffty, B. G., Oct 1 2019, In : Frontiers in Oncology. 9, 970.

Research output: Contribution to journal › Article

Open Access
Radiotherapy
Breast Neoplasms
Stroke Volume
Cardiotoxicity
Trastuzumab
3 Citations (Scopus)

A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance)

Rashkin, S. R., Chua, K. C., Ho, C., Mulkey, F., Jiang, C., Mushiroda, T., Kubo, M., Friedman, P. N., Rugo, H. S., McLeod, H. L., Ratain, M. J., Castillos, F., Naughton, M., Overmoyer, B., Toppmeyer, D., Witte, J. S., Owzar, K. & Kroetz, D. L., Mar 1 2019, In : Clinical pharmacology and therapeutics. 105, 3, p. 738-745 8 p.

Research output: Contribution to journal › Article

Pharmacogenetics
Disease-Free Survival
Area Under Curve
Genome
Breast Neoplasms

Assessment of Diagnostic Outcomes of RNA Genetic Testing for Hereditary Cancer

Karam, R., Conner, B., LaDuca, H., McGoldrick, K., Krempely, K., Richardson, M. E., Zimmermann, H., Gutierrez, S., Reineke, P., Hoang, L., Allen, K., Yussuf, A., Farber-Katz, S., Rana, H. Q., Culver, S., Lee, J., Nashed, S., Toppmeyer, D., Collins, D., Haynes, G. & 5 others, Pesaran, T., Dolinsky, J. S., Tippin Davis, B., Elliott, A. & Chao, E., Oct 2 2019, In : JAMA Network Open. 2, 10, p. e1913900

Research output: Contribution to journal › Article

Open Access
Genetic Testing
Outcome Assessment (Health Care)
RNA
Neoplasms
DNA
17 Citations (Scopus)

Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer

Sparano, J. A., Gray, R. J., Ravdin, P. M., Makower, D. F., Pritchard, K. I., Albain, K. S., Hayes, D. F., Geyer, C. E., Dees, E. C., Goetz, M. P., Olson, J. A., Lively, T., Badve, S. S., Saphner, T. J., Wagner, L. I., Whelan, T. J., Ellis, M. J., Paik, S., Wood, W. C., Keane, M. M. & 10 others, Gomez Moreno, H. L., Reddy, P. S., Goggins, T. F., Mayer, I. A., Brufsky, A. M., Toppmeyer, D. L., Kaklamani, V. G., Berenberg, J. L., Abrams, J. & Sledge, G. W., Jun 20 2019, In : New England Journal of Medicine. 380, 25, p. 2395-2405 11 p.

Research output: Contribution to journal › Article

Breast Neoplasms
Recurrence
Therapeutics
Drug Therapy
Confidence Intervals